Utilizing nuclear magnetic resonance (NMR) spectroscopy for assessing nadolol racemate composition.
NMR methods were developed for the determination of the racemate composition in nadolol raw materials. With high-field instruments (400 MHz or greater) the racemate ratio may be determined by the relative heights of the t-butyl peaks, which are well enough resolved for this determination. For lower field spectrometers, the t-butyl peaks are not resolved. An NMR method has been developed which involves preparation of the tribenzoate derivative of the drug. Seven lots of nadolol raw material, as well as several standards, were analysed for their racemate content. Three lots of raw material did not meet the USP limits of 40-60% for racemate A. Of these, two were granular in appearance and were found to vary markedly in racemate composition in successive analyses. The results for all the materials of uniform content agree very well with those from the HPLC method, as well as for the USP IR method using the absorbance at the corrected wavelength.
Dawson
B A
BA
Pharmaceutical Chemistry Division, Bureau of Drug Research, Health Canada, Sir F.G. Banting Research Centre, Ottawa, ON.
Black
D B
DB
D005069:Evaluation Studies as Topic; D009682:Magnetic Resonance Spectroscopy; D008674:Metals, Rare Earth; D009248:Nadolol / Q000032:analysis* / Q000737:chemistry; D013237:Stereoisomerism
D008674:Metals, Rare Earth; D009248:Nadolol